China Condemns EU Investigation May 17: Trade Tensions Escalate

China’s Commerce Ministry has issued a strong rebuke of the European Union’s investigation into Nuctech, a state-owned surveillance equipment manufacturer. The EU launched its probe in December 2025, suspecting the company of receiving illegal subsidies that create unfair competition. Nuctech produces security scanning systems used in airports, train stations, and metro systems across the globe. China argues the EU’s regulatory framework violates international trade principles and constitutes improper extraterritorial jurisdiction. This confrontation reflects deepening trade disputes between Beijing and Brussels over state subsidies and market access.

EU Investigation Triggers Beijing’s Formal Complaint

The EU initiated its investigation into Nuctech under a 2023 regulation designed to combat unfair competition from foreign companies receiving state subsidies. China’s Commerce Ministry condemned this action as creating artificial trade barriers. Beijing stated it had previously called for dialogue but accused the EU of persisting in “errors” and moving further astray from fair trade principles.

China’s statement emphasized that any organization or individual must not execute or assist in executing the EU’s measures. The ministry also labeled the investigation an improper exercise of extraterritorial jurisdiction, signaling Beijing’s intent to resist compliance.

Nuctech’s Role in Global Security Infrastructure

Nuctech, a subsidiary of China’s state-owned Tsinghua Tongfang Group, manufactures advanced security screening equipment deployed worldwide. The company produces body scanners and baggage X-ray systems critical to airport and transit security operations. Its technology is widely used across international transportation hubs, making it a strategically important player in global security markets.

The company acknowledged the EU’s investigation but has not publicly responded to China’s formal condemnation. Industry observers note that Nuctech’s market position depends on maintaining access to European contracts and partnerships.

Beijing Threatens Countermeasures and Market Retaliation

China’s Commerce Ministry warned it would closely monitor EU actions and take necessary measures to defend national security and Chinese enterprises’ legitimate rights. This language suggests potential retaliatory tariffs or trade restrictions targeting European companies operating in China. The Chinese Chamber of Commerce in the EU characterized the investigation as disproportionate and abusive targeting of Chinese firms.

The standoff reflects broader tensions over industrial policy, with Beijing viewing the EU’s subsidy rules as protectionist while Brussels argues it protects fair competition. Both sides appear entrenched, with little room for immediate compromise.

Broader Trade War Context and Implications

This dispute occurs amid escalating US-China trade tensions and growing EU scrutiny of Chinese state-owned enterprises. The EU’s investigation into Nuctech represents part of a wider pattern of regulatory actions targeting Chinese companies accused of receiving unfair government support. China’s formal condemnation signals Beijing’s willingness to escalate beyond diplomatic protests to potential economic retaliation, setting a concerning precedent for future trade disputes.

Final Thoughts

China’s condemnation of the EU’s Nuctech investigation marks a critical escalation in trade tensions between Beijing and Brussels. The dispute centers on competing visions of fair competition and state subsidies in global markets. With China threatening countermeasures and the EU maintaining its regulatory stance, both sides appear locked in a confrontational posture. The outcome will likely influence how other nations approach Chinese state-owned enterprises and set precedents for future trade disputes in an increasingly fragmented global economy.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.